Cdi 10:1 Us Prohib Excl Qib Deferred Settlement (EBRDA) - Total Liabilities
Based on the latest financial reports, Cdi 10:1 Us Prohib Excl Qib Deferred Settlement (EBRDA) has total liabilities worth AU$71.64 Million AUD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Cdi 10:1 Us Prohib Excl Qib Deferred Settlement - Total Liabilities Trend (2023–2025)
This chart illustrates how Cdi 10:1 Us Prohib Excl Qib Deferred Settlement's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Cdi 10:1 Us Prohib Excl Qib Deferred Settlement Competitors by Total Liabilities
The table below lists competitors of Cdi 10:1 Us Prohib Excl Qib Deferred Settlement ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Man Shing Agricultural Holdings Inc
PINK:MSAH
|
USA | $5.87 Million |
|
Fantasy Network Ltd
TA:FNTS
|
Israel | ILA755.00K |
|
Miton UK MicroCap Trust PLC
LSE:MINI
|
UK | GBX130.00K |
|
Canyon Bancorp
PINK:CYBA
|
USA | $266.89 Million |
Liability Composition Analysis (2023–2025)
This chart breaks down Cdi 10:1 Us Prohib Excl Qib Deferred Settlement's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.20 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.41 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.80 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.74 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cdi 10:1 Us Prohib Excl Qib Deferred Settlement's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cdi 10:1 Us Prohib Excl Qib Deferred Settlement (2023–2025)
The table below shows the annual total liabilities of Cdi 10:1 Us Prohib Excl Qib Deferred Settlement from 2023 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | AU$71.64 Million | +45.59% |
| 2024-12-31 | AU$49.20 Million | +2.85% |
| 2023-12-31 | AU$47.84 Million | -- |
About Cdi 10:1 Us Prohib Excl Qib Deferred Settlement
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization thera… Read more